Health Care · Nasdaq Stockholm · FYE 12-31 · Prices AT CLOSE 2026-07-28 (SEK) — end-of-day, never a live or intraday quote
Last SEK 322.60Day +2.15%Mkt cap $2.9B1Y +49.8%Off 52W high −11.5%Vol (1Y) 47.8%
Daily closing price, split-adjusted to the current basis; 2.8y shown of 2,153 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
No fair-value, short-interest or ownership figures on file for BIOA-B.ST.
| Sales (TTM)SEK 257.4M |
| Earnings (TTM)-SEK 177.1M |
| ROE−18.2% |
| Net margin−68.8% |
| ROIC−44.2% |
| Sales growth 3Y112.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (SEK). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+4.4% |
| 1Y+49.8% |
| 3Y+10.3% |
| 5Y+128.2% |
| Since incept. (ann.)+31.9% |
Total return through 2026-07-28 · series begins 2017-10-12. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)47.8% |
| Ann. volatility (3Y)60.3% |
| Sharpe (1Y)1.10 |
| Sharpe (3Y)0.37 |
| Max drawdown (1Y)−22.5% |
| Max drawdown (3Y)−57.6% |
| Beta (3Y vs SPY)1.27 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
No 13F holders on file for BIOA-B.ST.
No reported quarters on file for BIOA-B.ST.
